Latest News from: NIH, National Eye Institute (NEI)

Filters close
Newswise:Video Embedded babies-attend-to-clues-of-meaning-as-they-take-in-complex-visual-world
VIDEO
Released: 27-Mar-2024 11:05 AM EDT
Babies Attend to Clues of Meaning as They Take in Complex Visual World
NIH, National Eye Institute (NEI)

Findings from a National Eye Institute-supported study show for the first time that when babies look at photos of unfamiliar everyday scenes, such as an office or a lab, they tend to fixate on the same regions where adults find meaning. This inclination to home in on what’s interesting or meaningful grows more pronounced as babies age. The findings, published in Infancy, provide a more nuanced understanding of visual development, which may lead to earlier detection of brain-based causes of vision problems, such as cerebral/cortical visual impairment.

Newswise: NEI Study Points to ‘Ground Zero’ for AMD Development
Released: 27-Mar-2024 10:05 AM EDT
NEI Study Points to ‘Ground Zero’ for AMD Development
NIH, National Eye Institute (NEI)

National Eye Institute researchers studying human retinas discovered 87 target genes where a mix of environmental factors likely influence one’s risk of developing age-related macular degeneration (AMD), a leading cause of vision loss in people ages 65 and older.

Newswise: Inflammation-Reducing Drug Shows No Benefit for Dry Age-Related Macular Degeneration in Nih Trial
Released: 21-Mar-2024 11:30 AM EDT
Inflammation-Reducing Drug Shows No Benefit for Dry Age-Related Macular Degeneration in Nih Trial
NIH, National Eye Institute (NEI)

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI), part of the National Institutes of Health.

Newswise: New technique enhances quality control of lab-grown cells for AMD treatment
Released: 18-Jan-2024 3:05 PM EST
New technique enhances quality control of lab-grown cells for AMD treatment
NIH, National Eye Institute (NEI)

Researchers at the National Eye Institute (NEI) have improved a crucial step in the production of retinal pigment epithelium (RPE), a tissue they grow in the lab from patient blood cells and are testing in a clinical trial as treatment for age-related macular degeneration (AMD).

Newswise: Metabolomics: A New Approach to Understanding Glaucoma
Released: 14-Nov-2023 6:05 PM EST
Metabolomics: A New Approach to Understanding Glaucoma
NIH, National Eye Institute (NEI)

Glaucoma remains one of the most common causes of vision loss and blindness in the U.S. and much of the world, disproportionately affecting older people, African Americans, and Hispanics and Latinos.

Newswise: Scientists discover external protein network can help stabilize neural connections
10-Aug-2023 2:05 PM EDT
Scientists discover external protein network can help stabilize neural connections
NIH, National Eye Institute (NEI)

The Noelin family of secreted proteins bind to the external portion of AMPA glutamate receptors and stabilize them on the neuronal cellular membrane, a process necessary for transmission of full-strength signals between neurons, according to a study in mice from the National Eye Institute (NEI) and the University of Freiberg, Germany.

Newswise: Intraocular corticosteroids best for treating complications of chronic inflammatory eye condition
8-Jun-2023 9:00 AM EDT
Intraocular corticosteroids best for treating complications of chronic inflammatory eye condition
NIH, National Eye Institute (NEI)

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).

Newswise:Video Embedded nei-scientists-publish-recipe-for-making-blood-vessel-cells-from-patient-stem-cells
VIDEO
Released: 16-May-2023 9:30 AM EDT
NEI Scientists publish recipe for making blood vessel cells from patient stem cells
NIH, National Eye Institute (NEI)

Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.

Newswise: Extremely rare gene variants point to a potential cause of age-related macular degeneration
29-Mar-2023 2:00 PM EDT
Extremely rare gene variants point to a potential cause of age-related macular degeneration
NIH, National Eye Institute (NEI)

A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults.

Newswise: FDA-approved drug shows promise in lab models for blinding childhood disease 
Released: 29-Mar-2023 12:05 PM EDT
FDA-approved drug shows promise in lab models for blinding childhood disease 
NIH, National Eye Institute (NEI)

A National Eye Institute-led team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10), an inherited retinal ciliopathy disease that often results in severe visual impairment or blindness in early childhood.

Newswise: Visually navigating on foot uses unique brain region
Released: 15-Mar-2023 8:45 AM EDT
Visually navigating on foot uses unique brain region
NIH, National Eye Institute (NEI)

Using vision to efficiently move through an area by foot uses a unique region of the brain’s cortex, according to a small study funded by the National Eye Institute (NEI).

Newswise: AI-based systems can help identify rapidly advancing age-related macular degeneration
Released: 14-Mar-2023 3:35 PM EDT
AI-based systems can help identify rapidly advancing age-related macular degeneration
NIH, National Eye Institute (NEI)

Researchers supported by the National Eye Institute are developing artificial intelligence/machine learning (AI/ML)-based systems that not only screen for AMD but also predict which patients will likely progress to late within two years. The systems also evaluate separately one’s risk for developing late wet (neovascular) AMD from one’s risk for late dry (geographic atrophy) AMD.

Newswise: Eye experts weigh in on artificial tears in midst of infectious outbreak
Released: 2-Mar-2023 1:15 PM EST
Eye experts weigh in on artificial tears in midst of infectious outbreak
NIH, National Eye Institute (NEI)

Questions remain about artificial tears linked to an outbreak of Pseudomonas aeruginosa infections involving 64 people in 13 states, including 8 cases of vision loss, as well as lung and urinary tract infections, and one death. Federal agencies warned people to stop using EzriCare and Delsam Pharma artificial tears after tests of opened bottles used by those affected found a rare, extensively drug-resistant strain of P. aeruginosa. The strain had never been reported in the United States.What is clear is that eye health experts have advice for people using artificial tears, which are sold over the counter and widely used for eye irritation associated with dry eye disease, contact lens use, and refractive surgery, as well among those using other eye drops regularly, such as for glaucoma.

Newswise: Early anti-VEGF treatment of diabetic retinopathy yields no benefit to visual acuity
2-Feb-2023 11:05 AM EST
Early anti-VEGF treatment of diabetic retinopathy yields no benefit to visual acuity
NIH, National Eye Institute (NEI)

While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from the DRCR Retina Network.

Newswise: Zebrafish model helps explain eye development
Released: 12-Jan-2023 1:30 PM EST
Zebrafish model helps explain eye development
NIH, National Eye Institute (NEI)

Scientists at the National Eye Institute (NEI) have developed a zebrafish model of NEDBEH—a rare genetic disorder that can cause coloboma, where parts of the eye are missing due to developmental defects. The model provides a new tool for understanding the eye's embryonic development. The NEI is part of the National Institutes of Health.

Newswise:Video Embedded nih-researchers-use-3d-bioprinting-to-create-eye-tissue
VIDEO
20-Dec-2022 3:15 PM EST
NIH researchers use 3D bioprinting to create eye tissue
NIH, National Eye Institute (NEI)

Scientists used patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of the mechanisms of blinding diseases. The research team from the National Eye Institute (NEI), part of the National Institutes of Health, printed a combination of cells that form the outer blood-retina barrier—eye tissue that supports the retina's light-sensing photoreceptors. The technique provides a theoretically unlimited supply of patient-derived tissue to study degenerative retinal diseases such as age-related macular degeneration (AMD).

   
Newswise: NIH researchers home in on a new cause of Stargardt disease
Released: 27-Oct-2022 11:30 AM EDT
NIH researchers home in on a new cause of Stargardt disease
NIH, National Eye Institute (NEI)

Using a new stem-cell based model made from skin cells, scientists found the first direct evidence that Stargardt-related ABCA4 gene mutations affect a layer of cells in the eye called the retinal pigment epithelium (RPE).

Newswise:Video Embedded nih-scientists-discover-essential-step-in-recharging-the-eye-s-light-sensing-retina
VIDEO
Released: 26-Oct-2022 1:30 PM EDT
NIH Scientists Discover Essential Step in Recharging the Eye’s Light-Sensing Retina
NIH, National Eye Institute (NEI)

Scientists have discovered a mechanism by which an area of a protein shape-shifts to convert vitamin A into a form usable by the eye’s light-sensing photoreceptor cells.

Newswise:Video Embedded 3d-map-reveals-dna-organization-within-human-retina-cells
VIDEO
4-Oct-2022 1:05 PM EDT
3D map reveals DNA organization within human retina cells
NIH, National Eye Institute (NEI)

National Eye Institute researchers mapped the organization of human retinal cell chromatin, the fibers that package 3 billion nucleotide-long DNA molecules into compact structures that fit into chromosomes within each cell’s nucleus. The resulting comprehensive gene regulatory network provides insights into regulation of gene expression in general, and in retinal function, in both rare and common eye diseases. The study published in Nature Communications.

Newswise: NIH researchers develop gene therapy for rare ciliopathy
6-Sep-2022 8:05 AM EDT
NIH researchers develop gene therapy for rare ciliopathy
NIH, National Eye Institute (NEI)

Researchers from the National Eye Institute (NEI) have developed a gene therapy that rescues cilia defects in retinal cells affected by a type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood.

Newswise: High-Tech Imaging Reveals Details About Rare Eye Disorder
26-Jul-2022 10:05 PM EDT
High-Tech Imaging Reveals Details About Rare Eye Disorder
NIH, National Eye Institute (NEI)

Using a new imaging technique, researchers from the National Eye Institute have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing effective treatments for this and other rare diseases. NEI is part of the National Institutes of Health.

Newswise: NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye
Released: 18-Jul-2022 4:55 PM EDT
NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye
NIH, National Eye Institute (NEI)

Loss of the protein pigment epithelium-derived factor (PEDF), which protects retinal support cells, may drive age-related changes in the retina, according to a new study in mice from the National Eye Institute (NEI).

Newswise: A type of ‘step therapy’ is an effective strategy for diabetic eye disease
11-Jul-2022 3:40 PM EDT
A type of ‘step therapy’ is an effective strategy for diabetic eye disease
NIH, National Eye Institute (NEI)

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

Newswise: NIH Researchers Decode Retinal Circuits for Circadian Rhythm, Pupillary Light Response
Released: 6-Jul-2022 4:20 PM EDT
NIH Researchers Decode Retinal Circuits for Circadian Rhythm, Pupillary Light Response
NIH, National Eye Institute (NEI)

The eye’s light-sensing retina taps different circuits depending on whether it is generating image-forming vision or carrying out a non-vision function such as regulating pupil size or sleep/wake cycles, according to a new mouse study from the National Eye Institute (NEI) and the National Institute of Mental Health (NIMH).

Newswise:Video Embedded gene-therapy-for-rare-eye-disease-safe-but-lacks-efficacy-in-early-trial
VIDEO
Released: 7-Jun-2022 5:05 PM EDT
Gene Therapy for Rare Eye Disease Safe but Lacks Efficacy in Early Trial
NIH, National Eye Institute (NEI)

Byron Lam and collaborators at the University of Miami reported results from an 8-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy. They found no significant safety concerns; however, treatment failed to improve or slow vision loss, with even the highest dose.

Released: 2-Jun-2022 12:20 PM EDT
NIH study confirms benefit of supplements for slowing age-related macular degeneration
NIH, National Eye Institute (NEI)

The AREDS2 dietary supplement formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original AREDS formula.

Newswise:Video Embedded retinal-cell-map-could-advance-precise-therapies-for-blinding-diseases
VIDEO
Released: 6-May-2022 3:50 PM EDT
Retinal Cell Map Could Advance Precise Therapies for Blinding Diseases
NIH, National Eye Institute (NEI)

Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception. The scientists from the National Eye Institute (NEI) discovered five subpopulations of retinal pigment epithelium (RPE)—a layer of tissue that nourishes and supports the retina’s light-sensing photoreceptors. Using artificial intelligence, the researchers analyzed images of RPE at single-cell resolution to create a reference map that locates each subpopulation within the eye.

Newswise: Vision improvement is long-lasting with treatment for blinding blood vessel condition
Released: 21-Apr-2022 10:05 AM EDT
Vision improvement is long-lasting with treatment for blinding blood vessel condition
NIH, National Eye Institute (NEI)

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ongoing treatment.

Newswise: Advancing a Treatment for a Common Eye Disease That Lacks One
Released: 11-Apr-2022 11:05 AM EDT
Advancing a Treatment for a Common Eye Disease That Lacks One
NIH, National Eye Institute (NEI)

The road from discovering a potential drug to getting the therapy into the hands of patients is a long and uncertain one. An NIH program offers researchers a smoother path from basic science to clinical testing and regulatory approval.

Newswise: Attention to objects in peripheral vision is not driven by tiny eye movements
Released: 25-Mar-2022 2:00 PM EDT
Attention to objects in peripheral vision is not driven by tiny eye movements
NIH, National Eye Institute (NEI)

New research by National Eye Institute (NEI) investigators shows that while microsaccades seem to boost or diminish the strength of brain signals underlying attention, the eye movements are not drivers of those brain signals.

Newswise: NIH study classifies vision loss and retinal changes in Stargardt disease
Released: 25-Jan-2022 12:30 PM EST
NIH study classifies vision loss and retinal changes in Stargardt disease
NIH, National Eye Institute (NEI)

National Eye Institute researchers developed and validated an artificial-intelligence-based method to evaluate patients with Stargardt, an eye disease that can lead to childhood vision loss. The method quantifies disease-related loss of light-sensing retina cells, yielding information for monitoring patients, understanding genetic causes of the disease, and developing therapies to treat it.

Newswise: NIH researchers identify potential AMD drugs with stem-cell based research tool
14-Dec-2021 6:15 PM EST
NIH researchers identify potential AMD drugs with stem-cell based research tool
NIH, National Eye Institute (NEI)

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists. The scientists, from the National Eye Institute (NEI), part of the National Institutes of Health, published their findings today in Nature Communications.

Newswise:Video Embedded nih-study-traces-molecular-link-from-gene-to-late-onset-retinal-degeneration
VIDEO
7-Dec-2021 12:15 PM EST
NIH study traces molecular link from gene to late-onset retinal degeneration
NIH, National Eye Institute (NEI)

Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health generated a “disease-in-a-dish” model to study the disease. The findings are published in Communications Biology.

Newswise: NIH-funded study shows screening device accurately detects amblyopia (lazy eye)
Released: 27-Sep-2021 4:00 PM EDT
NIH-funded study shows screening device accurately detects amblyopia (lazy eye)
NIH, National Eye Institute (NEI)

A handheld screening device that detects subtle misalignment of the eyes accurately identifies children with amblyopia (lazy eye), according to a study published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.

Released: 8-Sep-2021 11:45 AM EDT
NIH-funded modern “white cane” brings navigation assistance to the 21st century
NIH, National Eye Institute (NEI)

Equipped with a color 3D camera, an inertial measurement sensor, and its own on-board computer, a newly improved robotic cane could offer blind and visually impaired users a new way to navigate indoors.

   
Released: 27-Jul-2021 9:30 AM EDT
Scientists Uncover How Decisions About What We See Are Relayed Back Through the Brain
NIH, National Eye Institute (NEI)

Researchers at the National Institutes of Health have discovered that decisions based on visual information, which involve a complex stream of data flowing forward and backwards along the brain’s visual pathways, is broadcast widely to neurons in the visual system, including to those that are not being used to make the decision.

19-Jul-2021 2:35 PM EDT
Scientists Discover Gene Therapy Provides Neuroprotection to Prevent Glaucoma Vision Loss
NIH, National Eye Institute (NEI)

A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH’s National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and blindness.

Released: 21-Jun-2021 9:45 AM EDT
NIH-Funded Study Shows Children Recycle Brain Regions When Acquiring New Skills
NIH, National Eye Institute (NEI)

Scientists studied the brain activity of school-aged children during development and found that regions that activated upon seeing limbs (hands, legs, etc.) subsequently activated upon seeing faces or words when the children grew older. The research, by scientists at Stanford University, Palo Alto, California, reveals new insights about vision development in the brain and could help inform prevention and treatment strategies for learning disorders. The study was funded by the National Eye Institute and is published in Nature Human Behaviour.

Released: 16-Jun-2021 4:05 PM EDT
Scientists unravel the function of a sight-saving growth factor
NIH, National Eye Institute (NEI)

Researchers at the National Eye Institute (NEI) have determined how certain short protein fragments, called peptides, can protect neuronal cells found in the light-sensing retina layer at the back of the eye. The peptides might someday be used to treat degenerative retinal diseases, such as age-related macular degeneration (AMD).

Released: 22-Apr-2021 2:15 PM EDT
Audacious projects develop imaging technology to aid eye tissue regeneration
NIH, National Eye Institute (NEI)

As regenerative therapies for blinding diseases move closer to clinical trials, the National Eye Institute’s functional imaging consortium, a part of the NEI Audacious Goals Initiative (AGI), is pioneering noninvasive technologies to monitor the function of the retina’s light-sensing neurons and their connections to the brain.

Released: 13-Apr-2021 1:15 PM EDT
An Artificial Retina Engineered From Ancient Protein Heads to Space
NIH, National Eye Institute (NEI)

NIH supported early testing of the artificial retina. Now, scientists are testing whether manufacturing it on the International Space Station results in a viable treatment for people with blinding eye diseases.

26-Mar-2021 12:00 PM EDT
Preventive treatment reduces diabetic retinopathy complications
NIH, National Eye Institute (NEI)

Early treatment with anti-VEGF injections slowed diabetic retinopathy in a clinical study from the DRCR Retina Network (DRCR.net). However, two years into the four-year study its effect on vision was similar to standard treatment, which usually begins at the onset of late disease.

Released: 18-Mar-2021 9:35 AM EDT
National Eye Institute launches data portal for macular degeneration research
NIH, National Eye Institute (NEI)

The National Eye Institute (NEI) Data Commons now enables researchers to access data from patients with macular degeneration who participated in the Age-related Eye Disease Study 2 (AREDS2). The database complements newly available stem cell lines created by the New York Stem Cell Foundation Research Institute (NYSCF) from blood cells of AREDS2 study participants.

25-Jan-2021 4:10 PM EST
Researchers use patients’ cells to test gene therapy for rare eye disease
NIH, National Eye Institute (NEI)

Scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy for a rare disease that causes severe vision loss in childhood. A form of Leber congenital amaurosis, the disease is caused by autosomal-dominant mutations in the CRX gene, which are challenging to treat with gene therapy.

Released: 17-Dec-2020 11:00 AM EST
NIH researchers discover brain area crucial for recognizing visual events
NIH, National Eye Institute (NEI)

Researchers at the National Eye Institute (NEI) report that a brain region in the superior temporal sulcus (fSTS) is crucial for processing and making decisions about visual information.

10-Dec-2020 4:20 PM EST
Surgical and drug treatment options lead to similar outcomes for diabetic eye disease
NIH, National Eye Institute (NEI)

Surgical and injectable drug approaches are equally effective for treatment of bleeding inside the eye from proliferative diabetic retinopathy (PDR), according to a National Eye Institute (NEI)-supported clinical study from the DRCR Retina Network (DRCR.net).

12-Nov-2020 12:00 PM EST
Envision color: Activity patterns in the brain are specific to the color you see
NIH, National Eye Institute (NEI)

Researchers at the National Eye Institute (NEI) have decoded brain maps of human color perception. The findings, published today in Current Biology, open a window into how color processing is organized in the brain, and how the brain recognizes and groups colors in the environment. The study may have implications for the development of machine-brain interfaces for visual prosthetics. NEI is part of the National Institutes of Health.

20-Oct-2020 8:30 AM EDT
Scientists use gene therapy and a novel light-sensing protein to restore vision in mice
NIH, National Eye Institute (NEI)

A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy. The National Eye Institute, part of the National Institutes of Health, provided a Small Business Innovation Research grant to Nanoscope, LLC for development of MCO1. The company is planning a U.S. clinical trial for later this year.

Released: 25-Sep-2020 6:05 PM EDT
Could a tiny fish hold the key to curing blindness?
NIH, National Eye Institute (NEI)

Imagine this: A patient learns that they are losing their sight because an eye disease has damaged crucial cells in their retina. Then, under the care of their doctor, they simply grow some new retinal cells, restoring their vision. Although science hasn’t yet delivered this happy ending, researchers are working on it – with help from the humble zebrafish. When a zebrafish loses its retinal cells, it grows new ones. This observation has encouraged scientists to try hacking the zebrafish’s innate regenerative capacity to learn how to treat human disease. That is why among the National Eye Institute’s 1,200 active research projects, nearly 80 incorporate zebrafish.


Showing results 1 – 50 of 173


close
1.21761